A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese

Internal Medicine Journal

Volumn 42, Issue 6, 2012, Pages

  Chen, H ^a   Sun, L Y ^a   Chen, L L ^a   Zheng, H Q ^a   Zhang, Q F ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Case control study; Colorectal cancer; Individual susceptibility; MicroRNA 196a2; Single nucleotide polymorphism

Indexed keywords

DNA; MICRORNA; MICRORNA 196A2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SUSCEPTIBILITY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HOMOZYGOTE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862532828     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02434.x     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Yang L, Parkin DM, Li L, Chen Y. Time trends in cancer mortality in China: 1987-1999. Int J Cancer 2003; 106: 771-83.
3. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
4. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
5. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H etal. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-75.
6. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y etal. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 2009; 15: 4009-16.
7. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J etal. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009; 26: 27-34.
8. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjøt L etal. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-24.
9. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J etal. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737-43.
10. Bandres E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N etal. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 5: 29.
11. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16: 1124-31.
12. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007; 104: 3300-5.
13. Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J etal. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008; 14: 7956-62.
14. Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G etal. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-7.
15. Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H etal. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum Mutat 2009; 30: 1231-6.
16. Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J etal. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79-84.
17. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L etal. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118: 2600-8.
18. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. New York, NY: John Wiley & Sons; 2002; 131-41.
19. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10: 789-99.
20. Rinaldi A, Poretti G, Kwee I, Zucca E, Catapano CV, Tibiletti MG etal. Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk Lymphoma 2007; 48: 410-12.
21. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E etal. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9.
22. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M etal. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 2007; 67: 1419-23.
23. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH etal. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-52.
24. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y etal. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-34.
25. Lum AM, Wang BB, Li L, Channa N, Bartha G, Wabl M. Retroviral activation of the mir-106a microRNA cistron in T lymphoma. Retrovirology 2007; 4: 5.
26. Slape C, Hartung H, Lin YW, Bies J, Wolff L, Aplan PD. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation. Cancer Res 2007; 67: 5148-55.
27. Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R etal. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 2006; 13: 13-21.